Duc Tran has seventeen year experience in drug discovery and drug development, working for large pharmaceutical companies (Sanofi-Aventis, Pfizer) and start-ups (Preglem, Prexton Therapeutics) and has extensive experience working across a range of target classes in multiple disease areas encompassing cardiovascular, anti-infective, urology, epigenetics, CNS and reproductive medicine, delivering a large number of projects into clinical development, up to PhIIa Proof of Concept. Duc has recently joined Arisgen in 2014 and is responsible for providing IND-enabling Preclinical, Clinical, Quality Assurance and Chemistry, Manufacturing and Control (CMC) leadership for the drug development programs to support regulatory submission. Duc graduated from the French Grandes Ecoles d’ingénieurs ESPCI in Physics, Chemistry and Biology. He also holds a MSc degree in organic and bioorganic chemistry from Paris VI and is a PRINCE2 registered Project Manager. Duc has published sixteen articles in peer reviewed journals and is a named inventor on six patents

 organic and bioorganic chemistry